Repligen Corporation (RGEN)

Repligen Corporation (RGEN) is a Medical Instruments & Supplies company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $11.3B; returns 1 day -1.0%, 1 week +0.9%, 1 year +7.1%.

Repligen Corporation (RGEN) is a global life sciences company that develops, manufactures, and commercializes innovative bioprocessing technologies and systems primarily for the production of biological drugs. Operating on a 'razor-and-blades' business model, the company sells specialized equipment and high-margin consumable products essential for efficient biopharmaceutical manufacturing.

Groups RGEN belongs to

• Life Sciences Tools & Services
• Healthcare
• Biotechnology
• Life Sciences
• Biopharmaceutical
• Biologics
• Healthcare Technology
• Manufacturing
• Monoclonal Antibodies
• Gene Therapy

RGEN financial model: income statement, cash flow and balance sheet